,Set,NGenes,Direction,PValue,FDR
1,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Up,1.43070698946088e-13,1.17890255931576e-10
2,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,24,Down,4.14034666334314e-11,1.70582282529737e-08
3,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Up,1.48815279421761e-10,4.08745967478436e-08
4,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Up,3.16204290331637e-10,6.51380838083172e-08
5,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Down,1.00331736801895e-07,1.65346702249522e-05
6,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,2.80272819892337e-07,3.84908005985476e-05
7,WP_MEVALONATE_PATHWAY,7,Up,1.17788613625657e-06,0.000138190044318478
8,WP_PROSTAGLANDIN_SIGNALING,24,Down,1.34165091571337e-06,0.000138190044318478
9,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,1.80258301211709e-06,0.000165036489109387
10,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,15,Down,2.26104758057686e-06,0.000186310320639533
11,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,43,Down,3.05723120445906e-06,0.000213542098349832
12,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,7,Down,3.30922879149802e-06,0.000213542098349832
13,WP_CHOLESTEROL_METABOLISM,53,Up,3.36898941571338e-06,0.000213542098349832
14,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,4.60598548235464e-06,0.000271095145532873
15,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Up,1.03105349730933e-05,0.000566392054521926
16,WP_VITAMIN_B12_METABOLISM,24,Down,1.26378965060034e-05,0.000650851670059177
17,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,68,Up,1.44501206440085e-05,0.000700405847686058
18,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Down,2.52554589824776e-05,0.00115613878897564
19,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,17,Down,3.90999719872242e-05,0.00164808377203474
20,WP_LUNG_FIBROSIS,36,Down,4.00020333018141e-05,0.00164808377203474
21,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,4.73331133185485e-05,0.00178806423620595
22,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,49,Down,4.77395791220036e-05,0.00178806423620595
23,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Up,8.67788232245347e-05,0.00310894566682681
24,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Down,0.000150577530161942,0.00516982853556002
25,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,50,Down,0.000300250945489277,0.00989627116332657
26,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,8,Down,0.000331038715690312,0.0104913808357237
27,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,19,Down,0.000432824527877565,0.0127823649272409
28,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.000442135239174964,0.0127823649272409
29,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Down,0.000459532111240273,0.0127823649272409
30,WP_IL18_SIGNALING,192,Down,0.000465377363855859,0.0127823649272409
31,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,18,Down,0.000510847211458031,0.0135786484594006
32,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.000535701975978002,0.0137943258814336
33,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,43,Down,0.000636707532996086,0.0158983941572356
34,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Up,0.000696144485530324,0.0168712663552055
35,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.000849509744011798,0.0199998865447349
36,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Up,0.000902004026478577,0.0200097451430171
37,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,7,Down,0.000908870211802608,0.0200097451430171
38,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Down,0.000922779509022633,0.0200097451430171
39,WP_BURN_WOUND_HEALING,62,Down,0.000966616152997579,0.0204228643607694
40,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.00104212343638858,0.0209259951850913
41,WP_VITAMIN_D_METABOLISM,6,Up,0.00106581074112768,0.0209259951850913
42,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,12,Down,0.00106943565315766,0.0209259951850913
43,WP_MEASLES_VIRUS_INFECTION,101,Down,0.00109201188465889,0.0209259951850913
44,WP_TYPE_II_INTERFERON_SIGNALING,30,Down,0.00122341196169992,0.0229111694645621
45,WP_IL26_SIGNALING,32,Down,0.00136690684769007,0.0247749119460626
46,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.00138306547271709,0.0247749119460626
47,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.00154880877211506,0.0271535835792088
48,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,3,Down,0.00162501889332719,0.0278305824909937
49,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Up,0.00165916656400252,0.0278305824909937
50,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Down,0.00170762029022731,0.0278305824909937
51,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Down,0.0017225239163115,0.0278305824909937
52,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,28,Down,0.00286327916710984,0.0453500606149609
53,WP_NUCLEAR_RECEPTORS_METAPATHWAY,180,Down,0.00291693351042831,0.0453500606149609
54,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,18,Down,0.00311023541286593,0.0474598885222504
55,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.00322965946132005,0.0483861708386859
56,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Up,0.00334645449974044,0.0492406876390379
57,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Down,0.00379174848965625,0.0546453708723008
58,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,139,Down,0.00385972342335712,0.0546453708723008
59,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,12,Down,0.00391271466197299,0.0546453708723008
60,WP_METABOLIC_EPILEPTIC_DISORDERS,58,Up,0.00441088839688142,0.0605762006505048
61,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.00462017902985789,0.0624102872229984
62,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Down,0.00485071596203292,0.0644675798825021
63,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,17,Down,0.00535694980709442,0.0700655022388223
64,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.00563367729557446,0.0725335951805211
65,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,24,Down,0.00610764625400069,0.0762973850729425
66,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Down,0.00611119831894928,0.0762973850729425
67,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.00629417123987872,0.0774089119650756
68,WP_VITAMIN_D_RECEPTOR_PATHWAY,87,Down,0.00724808812169261,0.0878297737099223
69,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.00741048856522829,0.0884962692427262
70,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Down,0.00866221083400114,0.0997854775129961
71,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,74,Up,0.00871899834270934,0.0997854775129961
72,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Down,0.00888883731016573,0.0997854775129961
73,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Down,0.00892432467202843,0.0997854775129961
74,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.00896131715529334,0.0997854775129961
75,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,77,Down,0.0093967471371216,0.103238928546509
76,WP_NGLYCAN_BIOSYNTHESIS,52,Up,0.00988624515260876,0.107187710601969
77,WP_NAD_METABOLISM,12,Down,0.0104019660689553,0.109909857063299
78,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,16,Down,0.0104474135095888,0.109909857063299
79,WP_LUNG_PATHOLOGY_OF_COVID19,15,Down,0.0105378077541663,0.109909857063299
80,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,39,Down,0.0108050214824072,0.109909857063299
81,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Down,0.0108893540909439,0.109909857063299
82,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,19,Down,0.0109723006194262,0.109909857063299
83,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Up,0.0110710171556478,0.109909857063299
84,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.0117980880942566,0.11573362606747
85,WP_TOLLLIKE_RECEPTOR_SIGNALING,80,Down,0.0125618455779515,0.121776008896847
86,WP_SMALL_CELL_LUNG_CANCER,71,Down,0.0128772508471013,0.123382031372227
87,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1,Down,0.0131166974613846,0.124231709289436
88,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,21,Up,0.0138687154918918,0.129861608696805
89,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,21,Down,0.0146996084803118,0.136095251548055
90,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Down,0.0149992255266766,0.137326242599795
91,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.0164515223772328,0.14793213820111
92,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Down,0.0165166950418715,0.14793213820111
93,WP_OREXIN_RECEPTOR_PATHWAY,118,Down,0.0168328758894713,0.149142900354025
94,WP_DISORDERS_IN_KETOLYSIS,4,Up,0.0174548489060516,0.152064280435143
95,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,47,Down,0.0175316828171585,0.152064280435143
96,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0181857463589215,0.156094322914076
97,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.0187974017564762,0.159681021106561
98,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Up,0.0194646525220668,0.16366197630799
99,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,277,Up,0.0202654025979185,0.168221705306655
100,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Down,0.0204168225087878,0.168221705306655
101,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Down,0.0207631225466617,0.168221705306655
102,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.0208235606083481,0.168221705306655
103,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Down,0.0216026713478015,0.172162634150816
104,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0219731820193735,0.172162634150816
105,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Down,0.0221049835621847,0.172162634150816
106,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,20,Down,0.0221471349757117,0.172162634150816
107,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Down,0.0224144120166631,0.17261192057692
108,WP_NEOVASCULARIZATION_PROCESSES,23,Down,0.0229522625664601,0.175117262544103
109,WP_SMALL_LIGAND_GPCRS,7,Down,0.0238517805045066,0.178699681589615
110,WP_GASTRIC_CANCER_NETWORK_1,18,Down,0.0238555400180312,0.178699681589615
111,WP_ONCOSTATIN_M_SIGNALING,56,Down,0.025774812116262,0.191337343998198
112,WP_OVARIAN_INFERTILITY,21,Down,0.0260125126336998,0.191377771519362
113,WP_NRXN1_DELETION_SYNDROME,2,Up,0.0263750597057704,0.19232786900491
114,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.0268365545253379,0.193976499376127
115,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Up,0.0274992474747846,0.19616830429132
116,WP_CANONICAL_NFKB_PATHWAY,8,Down,0.0276159263322732,0.19616830429132
117,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Up,0.0279479367689992,0.196829913655174
118,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Up,0.0291718186531312,0.202548933993629
119,WP_APOPTOSIS_MODULATION_AND_SIGNALING,79,Down,0.0292516057587886,0.202548933993629
120,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,10,Down,0.0296124966690278,0.203339143793991
121,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Up,0.0314857970429382,0.214415675730422
122,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Down,0.0320975967627507,0.216790325676284
123,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.0325969593056057,0.217944510989435
124,WP_PROXIMAL_TUBULE_TRANSPORT,25,Up,0.0329127289939196,0.217944510989435
125,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,13,Down,0.0333641976934741,0.217944510989435
126,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Down,0.0334375802065246,0.217944510989435
127,WP_FOLATE_METABOLISM,37,Down,0.0335909622520124,0.217944510989435
128,WP_OXIDATIVE_STRESS_RESPONSE,21,Down,0.0344733271787034,0.221922043712903
129,WP_TRYPTOPHAN_METABOLISM,19,Down,0.0354756074609556,0.226603880215716
130,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,129,Up,0.0369959211801334,0.23449722348023
131,WP_NEPHROGENESIS,4,Up,0.0380243595681903,0.237854793274452
132,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.0381029523206647,0.237854793274452
133,WP_ASPIRIN_AND_MIRNAS,8,Down,0.0393257764689024,0.24364240458929
134,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,100,Down,0.0398598233327005,0.245108167359293
135,WP_DNA_MISMATCH_REPAIR,21,Up,0.0407712603095278,0.248855692555933
136,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.0432371737762669,0.261966405820911
137,WP_WNT_SIGNALING_AND_PLURIPOTENCY,60,Up,0.0451251583446433,0.270360357607459
138,WP_WNT_SIGNALING_WP363,39,Up,0.045477694796896,0.270360357607459
139,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Up,0.0456069049847534,0.270360357607459
140,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Down,0.0469049201282603,0.276068958469189
141,WP_INTERFERONMEDIATED_SIGNALING,15,Down,0.0474042600155445,0.27702915072914
142,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.0488446867514413,0.282625303650829
143,WP_OXIDATIVE_DAMAGE_RESPONSE,33,Down,0.04904783789086,0.282625303650829
144,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.0494063488649398,0.282714107393822
145,WP_AEROBIC_GLYCOLYSIS,10,Up,0.0505392892118306,0.285235440483208
146,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.0505392892118306,0.285235440483208
147,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,37,Up,0.0520466752727717,0.291334300855882
148,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.0523270346197458,0.291334300855882
149,WP_APOPTOSIS,72,Down,0.0532329419264443,0.292773611136406
150,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Up,0.0532961670758021,0.292773611136406
151,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,63,Up,0.0560818134468586,0.306035856160341
152,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Up,0.057410201827463,0.310142077819332
153,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,78,Up,0.0575870605659681,0.310142077819332
154,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.0579634747544547,0.310142228556303
155,WP_SPINAL_CORD_INJURY,69,Down,0.0593949111910007,0.315751011750868
156,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Up,0.0599922614614121,0.316882201565408
157,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,8,Down,0.0609187153820447,0.319726251431878
158,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.0619065661709916,0.32285449699302
159,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.0627279380761067,0.324134056485294
160,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Up,0.0630159806001239,0.324134056485294
161,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.0633320183181217,0.324134056485294
162,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Up,0.0653551507372597,0.332423729675938
163,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.0662069218782259,0.332867365674352
164,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Up,0.0662503009351865,0.332867365674352
165,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Up,0.0681837797755477,0.333409970371715
166,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Up,0.0686342158367074,0.333409970371715
167,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Up,0.068892730210008,0.333409970371715
168,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.0689818784680673,0.333409970371715
169,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,10,Down,0.0690599012165831,0.333409970371715
170,WP_MATRIX_METALLOPROTEINASES,10,Down,0.0690653017218707,0.333409970371715
171,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.0693255064140719,0.333409970371715
172,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Up,0.069595285077591,0.333409970371715
173,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Down,0.0703788627463365,0.335214930075036
174,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.0719968051830377,0.340950387763351
175,WP_TCELL_ACTIVATION_SARSCOV2,61,Down,0.0738178973578685,0.347576842416478
176,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Down,0.0745166375703316,0.348873348624734
177,WP_PANCREATIC_CANCER_SUBTYPES,6,Down,0.0758284627382069,0.353009340656963
178,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,1,Down,0.0768567339896776,0.355786229255586
179,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Down,0.0773191153333512,0.35592710075241
180,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.0782427321804253,0.358177840648169
181,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Down,0.0821535923199899,0.372542050421113
182,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Up,0.0826192223475402,0.372542050421113
183,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,85,Down,0.0827368874114851,0.372542050421113
184,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.0837582854601685,0.375091452278146
185,WP_RANKLRANK_SIGNALING,47,Down,0.0864987871338464,0.384184525936554
186,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,13,Down,0.0867212643497562,0.384184525936554
187,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,3,Down,0.0887363131140377,0.391009208588059
188,WP_IL11_SIGNALING,40,Down,0.0895388174564668,0.392446731830471
189,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Up,0.0907539767647415,0.394175396598692
190,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.0922606009381167,0.394175396598692
191,WP_SERINE_METABOLISM,5,Up,0.0929176765129375,0.394175396598692
192,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.0931125570600005,0.394175396598692
193,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,12,Up,0.0931324235733655,0.394175396598692
194,WP_ALZHEIMERS_DISEASE,184,Up,0.0932817989523605,0.394175396598692
195,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,184,Up,0.0932817989523605,0.394175396598692
196,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.0987738945340175,0.415253515796074
197,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,49,Down,0.100630843751988,0.420526272430761
198,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Up,0.101048788763702,0.420526272430761
199,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.102963328380665,0.426340616008383
200,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,32,Down,0.10442678501902,0.430238354278362
201,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,79,Down,0.105088437722457,0.430810311857236
202,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,26,Up,0.10873611794693,0.440456628281355
203,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.110163938350752,0.440456628281355
204,WP_OSTEOBLAST_SIGNALING,3,Down,0.112303132222007,0.440456628281355
205,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.11318330075331,0.440456628281355
206,WP_OXIDATION_BY_CYTOCHROME_P450,15,Up,0.113639305291712,0.440456628281355
207,WP_HEPATITIS_B_INFECTION,118,Down,0.11404249675048,0.440456628281355
208,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Down,0.114247106255946,0.440456628281355
209,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,13,Up,0.11425762338233,0.440456628281355
210,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,21,Down,0.115350382593042,0.440456628281355
211,WP_G_PROTEIN_SIGNALING,62,Up,0.115361723816498,0.440456628281355
212,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,20,Up,0.115548077892589,0.440456628281355
213,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Down,0.116168362400074,0.440456628281355
214,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,12,Up,0.11616926119386,0.440456628281355
215,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Down,0.116339315839121,0.440456628281355
216,WP_ENDOCHONDRAL_OSSIFICATION,28,Down,0.116813858723737,0.440456628281355
217,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,28,Down,0.116813858723737,0.440456628281355
218,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Up,0.116910812683532,0.440456628281355
219,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Up,0.117509847522521,0.440456628281355
220,WP_STEROID_BIOSYNTHESIS,2,Up,0.118111230807885,0.440456628281355
221,WP_TNFALPHA_SIGNALING,83,Down,0.118132178216237,0.440456628281355
222,WP_ATM_SIGNALING,34,Down,0.118779862960836,0.440876608467249
223,WP_DNA_REPLICATION,36,Up,0.119322205353694,0.440903574939211
224,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.121217517273507,0.444526185325116
225,WP_MTHFR_DEFICIENCY,18,Up,0.121744149893518,0.444526185325116
226,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,57,Down,0.121921016848879,0.444526185325116
227,WP_MONOAMINE_GPCRS,4,Down,0.122680102991153,0.445323369448062
228,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.123357345494963,0.445817774946708
229,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Up,0.125173055988026,0.450223046960215
230,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Up,0.125669054369963,0.450223046960215
231,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Down,0.126242900329093,0.450320995113303
232,WP_SPINA_BIFIDA,10,Up,0.127545960388407,0.453008066207102
233,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Up,0.128508944818619,0.453898715470524
234,WP_ADIPOGENESIS,86,Down,0.129182474110178,0.453898715470524
235,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Up,0.129449269582006,0.453898715470524
236,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,13,Down,0.131949009605346,0.460703321672904
237,WP_COMPLEMENT_SYSTEM,53,Down,0.135193419326857,0.470039567617426
238,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,23,Down,0.136034514023853,0.470976636788466
239,WP_IL19_SIGNALING,20,Down,0.137313041572722,0.473414001070809
240,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Down,0.138240349585342,0.474625200243008
241,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,10,Down,0.140282232529532,0.478225839752675
242,WP_BLOOD_CLOTTING_CASCADE,5,Up,0.140670051850419,0.478225839752675
243,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Down,0.142320350107607,0.478225839752675
244,WP_GPCRS_OTHER,15,Down,0.142557957129527,0.478225839752675
245,WP_CELLULAR_PROTEOSTASIS,6,Up,0.143141011792045,0.478225839752675
246,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.143571783143772,0.478225839752675
247,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.144301179908834,0.478225839752675
248,WP_PREIMPLANTATION_EMBRYO,21,Down,0.144754601200741,0.478225839752675
249,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,18,Up,0.144774046901143,0.478225839752675
250,WP_COMPLEMENT_ACTIVATION,12,Down,0.145764995328281,0.478225839752675
251,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Down,0.146010850345195,0.478225839752675
252,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Down,0.146253533516595,0.478225839752675
253,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,67,Down,0.147875874773371,0.481619449854775
254,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Up,0.152072022954306,0.491110570484255
255,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Down,0.153001565936844,0.491110570484255
256,WP_ACE_INHIBITOR_PATHWAY,5,Up,0.153330466499483,0.491110570484255
257,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Down,0.153623251850581,0.491110570484255
258,WP_MITOCHONDRIAL_BETAOXIDATION,8,Up,0.153770057263274,0.491110570484255
259,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Down,0.15749685180996,0.501071065217789
260,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.159754769467227,0.506299730926905
261,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,40,Up,0.161071775896788,0.507555946619561
262,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Down,0.161383080114472,0.507555946619561
263,WP_PROTEASOME_DEGRADATION,57,Up,0.162387549613041,0.507789623573122
264,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.162690864353839,0.507789623573122
265,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.163306128940385,0.507789623573122
266,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,12,Up,0.164657281713205,0.510066165908575
267,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.167776294229007,0.514957918393671
268,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Up,0.16856526705688,0.514957918393671
269,WP_CREATINE_PATHWAY,2,Down,0.16862033625257,0.514957918393671
270,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.16873621112414,0.514957918393671
271,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.171492771442126,0.521439275528826
272,WP_TCELL_RECEPTOR_SIGNALING,73,Down,0.172773644668465,0.522329654796172
273,WP_GLIOBLASTOMA_SIGNALING,68,Down,0.173053392911839,0.522329654796172
274,WP_CORI_CYCLE,11,Up,0.174815823019083,0.525723496962497
275,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.178588213975109,0.535115230238146
276,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.179615127423268,0.535286620436928
277,WP_ATR_SIGNALING,10,Up,0.179944652743967,0.535286620436928
278,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.181398841096048,0.537599877158835
279,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,37,Down,0.182027142872955,0.537599877158835
280,WP_ERBB_SIGNALING,68,Down,0.185470788009565,0.544465001919708
281,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Down,0.18567313779058,0.544465001919708
282,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.188108984485648,0.549651784454517
283,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Up,0.188778397051856,0.549658654313531
284,WP_IL1_SIGNALING,53,Down,0.189746530079659,0.550532185864925
285,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.192437879821573,0.556048959655185
286,WP_CYTOSINE_METHYLATION,7,Up,0.193530651906325,0.556048959655185
287,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.194544386377204,0.556048959655185
288,WP_IL6_SIGNALING,39,Down,0.194676484755506,0.556048959655185
289,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Up,0.195509596755045,0.556048959655185
290,WP_SELENIUM_MICRONUTRIENT_NETWORK,51,Down,0.195696842597092,0.556048959655185
291,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,62,Down,0.197969435249373,0.56057324620441
292,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.204315202649609,0.576560708846843
293,WP_UROTENSINIIMEDIATED_SIGNALING,49,Down,0.207889367489011,0.582841207011869
294,WP_RETINOBLASTOMA_GENE_IN_CANCER,72,Up,0.207955479200837,0.582841207011869
295,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,17,Up,0.211437542876433,0.588403991793149
296,WP_BLADDER_CANCER,30,Down,0.21161498507909,0.588403991793149
297,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.212244299799308,0.588403991793149
298,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,46,Down,0.212796589264998,0.588403991793149
299,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.214011894274648,0.589574980752643
300,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.214949802811971,0.589574980752643
301,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.215430013079037,0.589574980752643
302,WP_MAPK_SIGNALING,164,Down,0.216082092460313,0.589574980752643
303,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,4,Down,0.216845959992267,0.58970650506148
304,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,4,Up,0.217934857952382,0.590718167607773
305,WP_GASTRIN_SIGNALING,93,Down,0.221100276394539,0.597333205734754
306,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,14,Up,0.222037760622698,0.597905603768311
307,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.223929974180737,0.600634458882488
308,WP_CHOLESTASIS,9,Up,0.224508996766755,0.600634458882488
309,WP_ANDROGEN_RECEPTOR_SIGNALING,78,Down,0.227121957747879,0.604608143172336
310,WP_15Q25_COPY_NUMBER_VARIATION,28,Up,0.228961675738975,0.604608143172336
311,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.228968602916456,0.604608143172336
312,WP_KREBS_CYCLE_DISORDERS,11,Up,0.229393569544256,0.604608143172336
313,WP_MRNA_PROCESSING,124,Up,0.229959406928991,0.604608143172336
314,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.230555350537002,0.604608143172336
315,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Down,0.233161637751457,0.604608143172336
316,WP_WNT_SIGNALING_WP428,60,Up,0.233194645983828,0.604608143172336
317,WP_KETOGENESIS_AND_KETOLYSIS,6,Down,0.233460877083424,0.604608143172336
318,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Down,0.233586261897027,0.604608143172336
319,WP_CCL18_SIGNALING,22,Down,0.234483494452625,0.604608143172336
320,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Down,0.2362331850981,0.604608143172336
321,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Down,0.237060611662733,0.604608143172336
322,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Up,0.23781717796088,0.604608143172336
323,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Down,0.239640926100798,0.604608143172336
324,WP_NOTCH_SIGNALING_WP268,35,Up,0.23973195855399,0.604608143172336
325,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.241218681359483,0.604608143172336
326,WP_RAC1PAK1P38MMP2_PATHWAY,52,Down,0.241299044157313,0.604608143172336
327,WP_AXON_GUIDANCE,36,Up,0.241889884543992,0.604608143172336
328,WP_HYPERTROPHY_MODEL,13,Down,0.242426101798909,0.604608143172336
329,WP_HIPPO_SIGNALING_REGULATION,45,Up,0.242526097376434,0.604608143172336
330,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Down,0.242788558721587,0.604608143172336
331,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Down,0.243154794613817,0.604608143172336
332,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.243604251860698,0.604608143172336
333,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Down,0.24480054158814,0.60575269149738
334,WP_GLYCOSPHINGOLIPID_METABOLISM,13,Down,0.247820830969982,0.610262737650368
335,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Up,0.248436652952015,0.610262737650368
336,WP_PARKINSONS_DISEASE_PATHWAY,27,Up,0.248844999818596,0.610262737650368
337,WP_IDO_METABOLIC_PATHWAY,8,Down,0.249852596868229,0.610915548425581
338,WP_MONOAMINE_TRANSPORT,12,Down,0.253664208950812,0.618400320045766
339,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.255456791965218,0.62093332324289
340,WP_DOPAMINE_METABOLISM,7,Up,0.259004761417132,0.62770565708152
341,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.260634694911832,0.629216070523723
342,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Down,0.261875634179904,0.629216070523723
343,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Down,0.262335225896373,0.629216070523723
344,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,36,Down,0.262682437208933,0.629216070523723
345,WP_IL2_SIGNALING,37,Down,0.269351439600934,0.640651025475013
346,WP_EBOLA_VIRUS_INFECTION_IN_HOST,109,Down,0.26963435247588,0.640651025475013
347,WP_GLUTATHIONE_METABOLISM,10,Down,0.270128048040072,0.640651025475013
348,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.270863725445127,0.640651025475013
349,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Down,0.271871208731128,0.640651025475013
350,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Down,0.272121188005163,0.640651025475013
351,WP_TRANSSULFURATION_PATHWAY,8,Up,0.27348081615846,0.642017642491655
352,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,48,Up,0.275067629389396,0.643211826823713
353,WP_ANGIOGENESIS,15,Down,0.278825344099808,0.643211826823713
354,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.278956437301473,0.643211826823713
355,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.2790664500607,0.643211826823713
356,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,50,Down,0.279073796419068,0.643211826823713
357,WP_ONECARBON_METABOLISM,22,Up,0.279960422177,0.643211826823713
358,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Up,0.280523024577847,0.643211826823713
359,WP_TGFB_SMAD_SIGNALING,7,Up,0.281433968187735,0.643211826823713
360,WP_INSULIN_SIGNALING,131,Up,0.282218137553533,0.643211826823713
361,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.2824532125006,0.643211826823713
362,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,47,Up,0.282576069551194,0.643211826823713
363,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.283861773156424,0.644358405181523
364,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,63,Down,0.285011110017808,0.645189985315039
365,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.285840511726697,0.645294744281639
366,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Down,0.287485663287337,0.646309209697561
367,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Up,0.287858592183258,0.646309209697561
368,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.289475033634079,0.648172357919787
369,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Down,0.291831683271044,0.649494330503857
370,WP_CELL_CYCLE,95,Up,0.29246083425789,0.649494330503857
371,WP_GABA_RECEPTOR_SIGNALING,9,Up,0.293406920851319,0.649494330503857
372,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.293960613453219,0.649494330503857
373,WP_FATTY_ACID_OMEGAOXIDATION,2,Down,0.294446347241419,0.649494330503857
374,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Up,0.294794756806362,0.649494330503857
375,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,3,Down,0.29857738891235,0.655465813526135
376,WP_KCNQ2RELATED_EPILEPSIES,11,Up,0.299096050832314,0.655465813526135
377,WP_AGERAGE_PATHWAY,55,Down,0.300601139976683,0.657016815227551
378,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.302294192148106,0.65896935007947
379,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Up,0.305592613107965,0.664401881796736
380,WP_MELANOMA,55,Down,0.308239378011635,0.668392756530493
381,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,20,Up,0.309531669354353,0.668681506366211
382,WP_PDGFRBETA_PATHWAY,27,Down,0.309995552708608,0.668681506366211
383,WP_NAD_BIOSYNTHETIC_PATHWAYS,20,Down,0.31273099519362,0.670204195962921
384,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.313484413196056,0.670204195962921
385,WP_NRF2_PATHWAY,73,Down,0.313877030446921,0.670204195962921
386,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Up,0.314712039019158,0.670204195962921
387,WP_ENDODERM_DIFFERENTIATION,82,Down,0.314768232812683,0.670204195962921
388,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,14,Up,0.315926877050185,0.670937491467404
389,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.318070462318855,0.673753370053308
390,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,71,Up,0.320171465952676,0.675928403329894
391,WP_BENZENE_METABOLISM,3,Down,0.320737870997559,0.675928403329894
392,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,64,Down,0.325452517343023,0.682933525260964
393,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Down,0.326075576195596,0.682933525260964
394,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,92,Up,0.326548311835946,0.682933525260964
395,WP_NEPHROTIC_SYNDROME,27,Up,0.328545694046545,0.685371270618616
396,WP_INCLUSION_BODY_MYOSITIS,9,Down,0.330038131964143,0.685754609720654
397,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Up,0.330704224981546,0.685754609720654
398,WP_NETRINUNC5B_SIGNALING,35,Down,0.332361615162919,0.685754609720654
399,WP_P38_MAPK_SIGNALING,31,Down,0.332623504779639,0.685754609720654
400,WP_GALANIN_RECEPTOR_PATHWAY,11,Down,0.333406609735012,0.685754609720654
401,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,12,Up,0.333867050062085,0.685754609720654
402,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.335498442796516,0.685754609720654
403,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.335969239600095,0.685754609720654
404,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.33710249409616,0.685754609720654
405,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.338599572983059,0.685754609720654
406,WP_HEME_BIOSYNTHESIS,8,Up,0.338599572983059,0.685754609720654
407,WP_IL9_SIGNALING,15,Down,0.338716172519789,0.685754609720654
408,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.34067562288806,0.688031159950396
409,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.341730621504981,0.688474406161623
410,WP_GPCRS_CLASS_A_RHODOPSINLIKE,46,Down,0.343257480075124,0.689458835316659
411,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Up,0.344465925610183,0.689458835316659
412,WP_DOPAMINERGIC_NEUROGENESIS,5,Down,0.344890001995817,0.689458835316659
413,WP_PPARALPHA_PATHWAY,15,Down,0.347161822410963,0.689458835316659
414,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Down,0.347371087868023,0.689458835316659
415,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Up,0.348221783842164,0.689458835316659
416,WP_LIPID_METABOLISM_PATHWAY,23,Up,0.348442176235962,0.689458835316659
417,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Down,0.3494232433336,0.689458835316659
418,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Down,0.350517275012553,0.689458835316659
419,WP_METASTATIC_BRAIN_TUMOR,6,Up,0.350684848781303,0.689458835316659
420,WP_VALPROIC_ACID_PATHWAY,9,Up,0.352527239274479,0.689458835316659
421,WP_LEPTIN_SIGNALING,69,Down,0.353337145608208,0.689458835316659
422,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.353420541119789,0.689458835316659
423,WP_EICOSANOID_SYNTHESIS,14,Down,0.354461425545718,0.689458835316659
424,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.354770080308572,0.689458835316659
425,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.357125257363045,0.690865671965082
426,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.357170844972239,0.690865671965082
427,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Up,0.359426718205373,0.692191927067127
428,WP_HIPPOYAP_SIGNALING,16,Up,0.359536583476615,0.692191927067127
429,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,47,Down,0.362916818472873,0.696758502072959
430,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,41,Up,0.364069466110813,0.696758502072959
431,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Up,0.364490868086276,0.696758502072959
432,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Up,0.366136445870863,0.696758502072959
433,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Up,0.366136445870863,0.696758502072959
434,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.368005905587807,0.697737739870707
435,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,73,Down,0.368983069363487,0.697737739870707
436,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.369191328378189,0.697737739870707
437,WP_ALLOGRAFT_REJECTION,51,Down,0.371162370027354,0.69880375224455
438,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Down,0.371464281583636,0.69880375224455
439,WP_TAR_SYNDROME,44,Down,0.37229957188757,0.69880375224455
440,WP_FOXA2_PATHWAY,9,Up,0.373478487657397,0.699423349612944
441,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.378202804719535,0.706664650995231
442,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Down,0.382793198955085,0.71362352022396
443,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,48,Down,0.386467806636655,0.715471589122544
444,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.387437560566509,0.715471589122544
445,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.387966532594293,0.715471589122544
446,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.387966532594293,0.715471589122544
447,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Up,0.388199751284964,0.715471589122544
448,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Down,0.389656447831172,0.715471589122544
449,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.389862552810707,0.715471589122544
450,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.39330743393933,0.718925117705763
451,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Down,0.39348935447245,0.718925117705763
452,WP_PYRIMIDINE_METABOLISM,71,Up,0.397422840723998,0.723639629669834
453,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Down,0.398221780219486,0.723639629669834
454,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Up,0.39924797815137,0.723639629669834
455,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Up,0.399582562499726,0.723639629669834
456,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Up,0.402752374509206,0.727780606569268
457,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.40440241018119,0.72916320785405
458,WP_PLEURAL_MESOTHELIOMA,258,Down,0.407094189416022,0.731665834735416
459,WP_PRIMARY_OVARIAN_INSUFFICIENCY,89,Down,0.407566284154801,0.731665834735416
460,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,15,Down,0.410257148430323,0.734328745993067
461,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,12,Up,0.410831980464568,0.734328745993067
462,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.412506654194729,0.735726153801854
463,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Up,0.413549238128637,0.735992596583146
464,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,64,Up,0.415165740372988,0.737277090662376
465,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,23,Down,0.416161439223903,0.737455969721497
466,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.420771687808571,0.740819341738804
467,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.421677777235074,0.740819341738804
468,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.423368214498411,0.740819341738804
469,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Up,0.423793277718746,0.740819341738804
470,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Down,0.423808083557743,0.740819341738804
471,WP_BDNFTRKB_SIGNALING,26,Up,0.424037490682596,0.740819341738804
472,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,15,Down,0.42443047130196,0.740819341738804
473,WP_GABA_METABOLISM_AKA_GHB,4,Up,0.425251879420454,0.740819341738804
474,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,55,Down,0.429218655627954,0.745520932791862
475,WP_FATTY_ACID_TRANSPORTERS,10,Down,0.430672171727292,0.745520932791862
476,WP_INTEGRINMEDIATED_CELL_ADHESION,74,Down,0.431340344992549,0.745520932791862
477,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,10,Up,0.431569763278784,0.745520932791862
478,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Down,0.432905797963135,0.74626438812055
479,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Down,0.437013536160093,0.751772763665797
480,WP_PDGF_PATHWAY,36,Down,0.439056875853146,0.753284714456877
481,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.439720810259415,0.753284714456877
482,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,41,Down,0.443664370395179,0.758463570966033
483,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Up,0.446341394496294,0.761460267215209
484,WP_CILIOPATHIES,128,Down,0.449271184452787,0.763408732752531
485,WP_PURINERGIC_SIGNALING,15,Up,0.44945976714137,0.763408732752531
486,WP_MALE_INFERTILITY,70,Down,0.450403201857176,0.763408732752531
487,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,21,Down,0.451189384527285,0.763408732752531
488,WP_OSTEOPONTIN_SIGNALING,12,Down,0.452470615272989,0.764007760215048
489,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.453622431205704,0.764386264444786
490,WP_16P112_DISTAL_DELETION_SYNDROME,21,Down,0.454550695928141,0.764387292744465
491,WP_PURINE_METABOLISM,10,Up,0.463365649420339,0.776322556065737
492,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Up,0.463532399980998,0.776322556065737
493,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,21,Down,0.466488744857459,0.777326626941323
494,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.466899996929368,0.777326626941323
495,WP_AMINO_ACID_METABOLISM,60,Up,0.466961990698974,0.777326626941323
496,WP_LIVER_X_RECEPTOR_PATHWAY,5,Down,0.469977943801163,0.780769809863223
497,WP_EGFEGFR_SIGNALING,140,Down,0.471319088397549,0.781422392031349
498,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Down,0.474481279703955,0.783726209133412
499,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Down,0.475273541128411,0.783726209133412
500,WP_IRON_METABOLISM_DISORDERS,13,Down,0.476028590735722,0.783726209133412
501,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,18,Down,0.476716570652755,0.783726209133412
502,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,50,Down,0.478217687086542,0.783726209133412
503,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.478415392225857,0.783726209133412
504,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,36,Up,0.479893287083872,0.783753408962899
505,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,20,Down,0.48060451469852,0.783753408962899
506,WP_ALSTROM_SYNDROME,27,Up,0.481975083092888,0.783753408962899
507,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.482236624204114,0.783753408962899
508,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Up,0.483840869071191,0.784812748257207
509,WP_ENDOMETRIAL_CANCER,49,Down,0.485283730730568,0.785606668216086
510,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Up,0.491420980923048,0.793982133883513
511,WP_LEUKOTRIENE_METABOLIC_PATHWAY,9,Up,0.493777882999606,0.794818311132024
512,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,58,Up,0.496999769663213,0.794818311132024
513,WP_NONSMALL_CELL_LUNG_CANCER,60,Down,0.497177360125225,0.794818311132024
514,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Down,0.497593569975554,0.794818311132024
515,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,27,Down,0.497832209739094,0.794818311132024
516,WP_NEURAL_CREST_DIFFERENTIATION,40,Down,0.497997030790374,0.794818311132024
517,WP_CARDIAC_HYPERTROPHIC_RESPONSE,45,Up,0.498690615115602,0.794818311132024
518,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,18,Down,0.500948112879191,0.796534020044809
519,WP_METHYLATION_PATHWAYS,5,Up,0.501921023905212,0.796534020044809
520,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Down,0.503369710386462,0.796534020044809
521,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.503633767528332,0.796534020044809
522,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.505451369017921,0.796750404502734
523,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.505704443634624,0.796750404502734
524,WP_GLYOXYLATE_METABOLISM,5,Up,0.510092627282134,0.801333326434428
525,WP_NUCLEAR_RECEPTORS,20,Down,0.510558248031644,0.801333326434428
526,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Up,0.512042030914477,0.802134284170207
527,WP_FERROPTOSIS,52,Down,0.513641735227373,0.802661362587033
528,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Up,0.51432669835674,0.802661362587033
529,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,175,Up,0.518623698625712,0.804691029592274
530,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.519345140964329,0.804691029592274
531,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,53,Up,0.519449052953873,0.804691029592274
532,WP_CANNABINOID_RECEPTOR_SIGNALING,17,Up,0.519533528814429,0.804691029592274
533,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Up,0.525154043478147,0.811870416183852
534,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,30,Down,0.526616224931878,0.812606309632711
535,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Down,0.529941000088292,0.815708769115925
536,WP_PRION_DISEASE_PATHWAY,28,Down,0.53060667505599,0.815708769115925
537,WP_SLEEP_REGULATION,11,Up,0.532455578338334,0.816753665470137
538,WP_THIAMINE_METABOLIC_PATHWAYS,9,Up,0.534268487133069,0.816753665470137
539,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Down,0.535599000989922,0.816753665470137
540,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Down,0.536132472469433,0.816753665470137
541,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.537152743107675,0.816753665470137
542,WP_GASTRIC_CANCER_NETWORK_2,26,Down,0.537515743984798,0.816753665470137
543,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,88,Up,0.538224806250345,0.816753665470137
544,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Down,0.54082626093472,0.819192718768768
545,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.542057789893914,0.819551594261625
546,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,24,Down,0.543079712937745,0.819592826851103
547,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Down,0.54524260008629,0.820152387768728
548,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,19,Down,0.545441151088911,0.820152387768728
549,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,13,Down,0.547378687570131,0.820847829359499
550,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Down,0.547896002606462,0.820847829359499
551,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Up,0.549614242688147,0.821927651497338
552,WP_CANCER_PATHWAYS,309,Down,0.551807628282872,0.822575665451494
553,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.552979092438699,0.822575665451494
554,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.553042377014718,0.822575665451494
555,WP_ALPHA_6_BETA_4_SIGNALING,26,Down,0.555613673393853,0.824911111489253
556,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Up,0.55854833493055,0.827089420908777
557,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,88,Up,0.559278906737434,0.827089420908777
558,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.56009210784842,0.827089420908777
559,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.562158428000552,0.828655714977557
560,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Up,0.564292199958874,0.830315665653772
561,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Up,0.56608510404302,0.830617735421194
562,WP_MIRNA_BIOGENESIS,6,Down,0.566658217692174,0.830617735421194
563,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.567521583788995,0.830617735421194
564,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.569260103559507,0.830670760453425
565,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Down,0.57033770598964,0.830670760453425
566,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Up,0.570629438266416,0.830670760453425
567,WP_CILIARY_LANDSCAPE,185,Up,0.571590195603267,0.830670760453425
568,WP_REGULATION_OF_ACTIN_CYTOSKELETON,93,Up,0.572688325399422,0.830801373466767
569,WP_FOCAL_ADHESION,122,Up,0.576270581864688,0.834068148911301
570,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Down,0.576964617572137,0.834068148911301
571,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.582453437165331,0.837245255226715
572,WP_G13_SIGNALING,29,Up,0.58265613689746,0.837245255226715
573,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.582838286831832,0.837245255226715
574,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Up,0.583226670509872,0.837245255226715
575,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.584299662163146,0.837326820212925
576,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Up,0.589633217436289,0.84350307494358
577,WP_ACETYLCHOLINE_SYNTHESIS,4,Up,0.597586106616509,0.851982443662031
578,WP_TP53_NETWORK,16,Down,0.597702631027388,0.851982443662031
579,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.59930821882421,0.851982443662031
580,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.60015741431012,0.851982443662031
581,WP_NOTCH_SIGNALING_WP61,49,Up,0.600730339523835,0.851982443662031
582,WP_NPHP1_DELETION_SYNDROME,10,Up,0.603662699084528,0.853956906893159
583,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,44,Down,0.605067745517953,0.853956906893159
584,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Up,0.605231594205831,0.853956906893159
585,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.606847246216376,0.854772873303066
586,WP_BREAST_CANCER_PATHWAY,88,Down,0.609066619340422,0.855493328483745
587,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Down,0.610415597922671,0.855493328483745
588,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,23,Down,0.610473394597624,0.855493328483745
589,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,16,Down,0.614059820639687,0.85905822106469
590,WP_ZINC_HOMEOSTASIS,25,Up,0.615576568833344,0.85963884351454
591,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Down,0.616561354996472,0.85963884351454
592,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.619726749340834,0.861593596985382
593,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Up,0.620054615306227,0.861593596985382
594,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.624959051151364,0.86524899111934
595,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.624959051151364,0.86524899111934
596,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,53,Up,0.625931494394257,0.86524899111934
597,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Down,0.626885494779425,0.86524899111934
598,WP_TCA_CYCLE_IN_SENESCENCE,10,Up,0.631014435148862,0.868101254654887
599,WP_INFLAMMATORY_RESPONSE_PATHWAY,14,Down,0.631335805512725,0.868101254654887
600,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.632112564069092,0.868101254654887
601,WP_SYNAPTIC_VESICLE_PATHWAY,22,Up,0.636411003629745,0.872550194660416
602,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Down,0.637496824445672,0.872587015520322
603,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.64100479382341,0.875933582272786
604,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,28,Up,0.64287255085564,0.877031426995112
605,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,48,Up,0.644962644821732,0.878428461707615
606,WP_BARDETBIEDL_SYNDROME,65,Down,0.647869861616081,0.880931957048929
607,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.649083708266177,0.881128460644696
608,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,128,Up,0.650570394081384,0.881694086715559
609,WP_ACUTE_MYELOID_LEUKEMIA,56,Down,0.651958859886547,0.882124959846493
610,WP_4P163_COPY_NUMBER_VARIATION,21,Up,0.656118368076291,0.885982728060888
611,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.656960493744178,0.885982728060888
612,WP_DNA_DAMAGE_RESPONSE,59,Down,0.658676244782719,0.88684514003425
613,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Down,0.663899018746396,0.888996963182579
614,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.665229788321497,0.888996963182579
615,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.666752776598263,0.888996963182579
616,WP_NRF2ARE_REGULATION,21,Down,0.667146549305059,0.888996963182579
617,WP_JOUBERT_SYNDROME,71,Up,0.668338984408714,0.888996963182579
618,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,20,Down,0.668382675115637,0.888996963182579
619,WP_THERMOGENESIS,74,Down,0.670610154532815,0.888996963182579
620,WP_UNFOLDED_PROTEIN_RESPONSE,24,Up,0.673090240879757,0.888996963182579
621,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Down,0.673188870135564,0.888996963182579
622,WP_PPAR_SIGNALING,39,Down,0.673538516459779,0.888996963182579
623,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Down,0.675634512408791,0.888996963182579
624,WP_HUNGER_AND_SATIETY,2,Down,0.677395814500145,0.888996963182579
625,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,168,Down,0.677418150207094,0.888996963182579
626,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,19,Up,0.677420510561716,0.888996963182579
627,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.677911717518871,0.888996963182579
628,WP_KININKALLIKREIN_PATHWAY,2,Up,0.679647585653862,0.888996963182579
629,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Up,0.680558866566124,0.888996963182579
630,WP_FATTY_ACID_BETAOXIDATION,29,Up,0.681831812776297,0.888996963182579
631,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.684544787034315,0.888996963182579
632,WP_KALLMANN_SYNDROME,11,Up,0.686024283544244,0.888996963182579
633,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Up,0.686026087085073,0.888996963182579
634,WP_SPHINGOLIPID_PATHWAY,21,Down,0.686646530520042,0.888996963182579
635,WP_FRAGILE_X_SYNDROME,84,Up,0.686672943310331,0.888996963182579
636,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Up,0.689318461767196,0.888996963182579
637,WP_RETINOL_METABOLISM,6,Down,0.690658343391122,0.888996963182579
638,WP_GPR40_PATHWAY,8,Down,0.691691654174212,0.888996963182579
639,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.692106857554155,0.888996963182579
640,WP_OSTEOCLAST_SIGNALING,9,Up,0.692281857938129,0.888996963182579
641,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.693410457273801,0.888996963182579
642,WP_PROLACTIN_SIGNALING,70,Down,0.694870780403302,0.888996963182579
643,WP_ECTODERM_DIFFERENTIATION,78,Down,0.695348118196642,0.888996963182579
644,WP_ENERGY_METABOLISM,41,Down,0.695808357188435,0.888996963182579
645,WP_IL17_SIGNALING,25,Down,0.696827522218389,0.888996963182579
646,WP_B_CELL_RECEPTOR_SIGNALING,86,Down,0.696956357058187,0.888996963182579
647,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Up,0.69926486428282,0.890562980168538
648,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.703485567113337,0.893048426103801
649,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.70482436994983,0.893048426103801
650,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,17,Up,0.705550800349281,0.893048426103801
651,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.705551608487348,0.893048426103801
652,WP_COPPER_HOMEOSTASIS,41,Up,0.712548659789728,0.90052161912076
653,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Down,0.715293612364986,0.902589091381992
654,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,30,Down,0.7165931949223,0.902589091381992
655,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Up,0.717470697639811,0.902589091381992
656,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,26,Down,0.719144843819044,0.903044900531196
657,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Up,0.72006621116807,0.903044900531196
658,WP_FLUOROACETIC_ACID_TOXICITY,6,Up,0.721120806492144,0.903044900531196
659,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.722786239461319,0.903756997444806
660,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,82,Down,0.72489502409004,0.903766641506881
661,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.72498756072336,0.903766641506881
662,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.726191870650199,0.903900455310821
663,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.729167945925876,0.906235878496112
664,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.731089227520998,0.90725530644172
665,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Down,0.735768695249941,0.910815401300477
666,WP_RETT_SYNDROME,32,Down,0.736168758818104,0.910815401300477
667,WP_KIT_RECEPTOR_SIGNALING,52,Down,0.739271410195699,0.913282821591088
668,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,16,Up,0.740922462080557,0.91395225861434
669,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.74480799373267,0.917371878678206
670,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Up,0.748932014165344,0.921074596525736
671,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.754763793018962,0.926863435838487
672,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Down,0.757219535748131,0.92838148095372
673,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Down,0.758676517160527,0.92838148095372
674,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Down,0.759379997770397,0.92838148095372
675,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Down,0.761976895987442,0.93017624043504
676,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.769558148385403,0.938041293298183
677,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Up,0.773688959301922,0.940984772241596
678,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.774256887839565,0.940984772241596
679,WP_CIRCADIAN_RHYTHM_GENES,121,Down,0.778121472207343,0.944288796905523
680,WP_TAMOXIFEN_METABOLISM,2,Up,0.782170738269742,0.945968265043008
681,WP_VEGFAVEGFR2_SIGNALING,343,Down,0.782445279968006,0.945968265043008
682,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,15,Down,0.784015993465417,0.945968265043008
683,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,20,Up,0.784210481092201,0.945968265043008
684,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Down,0.785245501564827,0.945968265043008
685,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Down,0.7945918723688,0.953552006833168
686,WP_CHEMOKINE_SIGNALING,115,Down,0.795206587585682,0.953552006833168
687,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Up,0.796330305279901,0.953552006833168
688,WP_ETHER_LIPID_BIOSYNTHESIS,16,Up,0.797017684835043,0.953552006833168
689,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Up,0.797711409116729,0.953552006833168
690,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Down,0.798484083391852,0.953552006833168
691,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,60,Down,0.808601407187677,0.963345899388257
692,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,64,Up,0.809023498029944,0.963345899388257
693,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,74,Down,0.812305904913028,0.964275894174948
694,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.812709937020454,0.964275894174948
695,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Down,0.813727900510353,0.964275894174948
696,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,26,Up,0.814485464011849,0.964275894174948
697,WP_NEUROINFLAMMATION,10,Down,0.816112233716236,0.964726419022443
698,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.819560026970085,0.964726419022443
699,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.819560026970085,0.964726419022443
700,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Up,0.820378448692549,0.964726419022443
701,WP_RAS_SIGNALING,119,Up,0.823728706506391,0.964726419022443
702,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Up,0.82423053629366,0.964726419022443
703,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.825021823301175,0.964726419022443
704,WP_TRANSLATION_FACTORS,48,Down,0.825309476074613,0.964726419022443
705,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.828164384962238,0.964726419022443
706,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.828431052724616,0.964726419022443
707,WP_ID_SIGNALING,12,Down,0.828785565856014,0.964726419022443
708,WP_ESTROGEN_SIGNALING,21,Up,0.828915418286274,0.964726419022443
709,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.831223360247587,0.965546754857293
710,WP_HEART_DEVELOPMENT,17,Up,0.832029975414005,0.965546754857293
711,WP_IL4_SIGNALING,50,Down,0.835365907718812,0.965546754857293
712,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.835435261609025,0.965546754857293
713,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Up,0.835479170161711,0.965546754857293
714,WP_CAMKK2_PATHWAY,30,Up,0.838599347168264,0.96731520663253
715,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,9,Down,0.840260691943651,0.96731520663253
716,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Down,0.841835778988043,0.96731520663253
717,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,57,Down,0.842088925154903,0.96731520663253
718,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Down,0.843836804192101,0.96731520663253
719,WP_FOXP3_IN_COVID19,9,Down,0.844052953360181,0.96731520663253
720,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,6,Up,0.846969639894762,0.968562578063002
721,WP_IL5_SIGNALING,37,Up,0.850321371252411,0.968562578063002
722,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Down,0.850674837544373,0.968562578063002
723,WP_VITAMIN_B12_DISORDERS,9,Up,0.850793482270544,0.968562578063002
724,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,3,Up,0.852140300744996,0.968562578063002
725,WP_TROP2_REGULATORY_SIGNALING,42,Down,0.852663251856122,0.968562578063002
726,WP_AUTOPHAGY,27,Up,0.853921486321112,0.968562578063002
727,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,55,Up,0.854544895936654,0.968562578063002
728,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Down,0.8577343183115,0.969185535660941
729,WP_SEROTONIN_AND_ANXIETY,7,Down,0.858025814764117,0.969185535660941
730,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,33,Down,0.858623108049135,0.969185535660941
731,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Down,0.862217940279515,0.971435527411733
732,WP_ARYLAMINE_METABOLISM,1,Up,0.863492468794161,0.971435527411733
733,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,31,Down,0.864153205816505,0.971435527411733
734,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.866550639990365,0.971602461058503
735,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Down,0.868013360386069,0.971602461058503
736,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,28,Down,0.868100496259306,0.971602461058503
737,WP_ENDOTHELIN_PATHWAYS,12,Up,0.869018220631209,0.971602461058503
738,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Down,0.872971657309094,0.973918320133997
739,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.874060091717104,0.973918320133997
740,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Down,0.875397697956305,0.973918320133997
741,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.875817324295257,0.973918320133997
742,WP_IL3_SIGNALING,46,Up,0.878047888672062,0.975082830546872
743,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.881819166893465,0.977063002276363
744,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Down,0.88602316895053,0.977063002276363
745,WP_IL7_SIGNALING,23,Down,0.8867280138238,0.977063002276363
746,WP_G1_TO_S_CELL_CYCLE_CONTROL,53,Down,0.887507499514658,0.977063002276363
747,WP_OPIOID_RECEPTOR_PATHWAYS,26,Up,0.889160880397636,0.977063002276363
748,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.889352367318486,0.977063002276363
749,WP_BASE_EXCISION_REPAIR,29,Up,0.890635041867638,0.977063002276363
750,WP_BENZOAPYRENE_METABOLISM,5,Down,0.892616413328728,0.977063002276363
751,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.892917014397624,0.977063002276363
752,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,9,Up,0.894060108688078,0.977063002276363
753,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Down,0.894987337915291,0.977063002276363
754,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.895776002958622,0.977063002276363
755,WP_HISTONE_MODIFICATIONS,37,Down,0.896543714154824,0.977063002276363
756,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,33,Up,0.897465390343123,0.977063002276363
757,WP_IRINOTECAN_PATHWAY,5,Up,0.898789080794695,0.977063002276363
758,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Up,0.900208169952823,0.977063002276363
759,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.900716330103705,0.977063002276363
760,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Down,0.903027205605136,0.977063002276363
761,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.903879321010801,0.977063002276363
762,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.904288309457902,0.977063002276363
763,WP_DRAVET_SYNDROME,14,Down,0.904731881962215,0.977063002276363
764,WP_GLUCURONIDATION,7,Up,0.906348821007734,0.977528047788446
765,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Up,0.90832966302176,0.978383846182915
766,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Up,0.91500675799246,0.980637728392382
767,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,20,Up,0.915541138199435,0.980637728392382
768,WP_6Q16_COPY_NUMBER_VARIATION,5,Up,0.915753608749038,0.980637728392382
769,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Down,0.915799003524494,0.980637728392382
770,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.917450985212976,0.980637728392382
771,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.917562728871998,0.980637728392382
772,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Down,0.922680383241822,0.982791292865463
773,WP_KLEEFSTRA_SYNDROME,25,Up,0.92435087915353,0.982791292865463
774,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Up,0.924963938830896,0.982791292865463
775,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.927601487478368,0.982791292865463
776,WP_INTEGRATED_CANCER_PATHWAY,40,Down,0.927781259822608,0.982791292865463
777,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Up,0.928976546767053,0.982791292865463
778,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.931630797936794,0.982791292865463
779,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,16,Down,0.931915325115976,0.982791292865463
780,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.931937560085921,0.982791292865463
781,WP_SILDENAFIL_TREATMENT,11,Down,0.932616636318253,0.982791292865463
782,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Up,0.932697561918437,0.982791292865463
783,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,12,Up,0.934477484616072,0.982893964729357
784,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.936098628163737,0.982893964729357
785,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Up,0.937094766449898,0.982893964729357
786,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.937566330433586,0.982893964729357
787,WP_IRON_METABOLISM_IN_PLACENTA,10,Up,0.940705506844062,0.984877261124246
788,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,9,Up,0.942739849974973,0.984877261124246
789,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,31,Down,0.943043882314357,0.984877261124246
790,WP_PI3KAKT_SIGNALING,181,Down,0.945011913681637,0.985349076473311
791,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Down,0.946637844548395,0.985349076473311
792,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.947083092920949,0.985349076473311
793,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Down,0.950636902232981,0.986151528027305
794,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Down,0.952194037631401,0.986151528027305
795,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.953062361742019,0.986151528027305
796,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,57,Up,0.953439338938005,0.986151528027305
797,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,7,Down,0.954192826662586,0.986151528027305
798,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,14,Up,0.956453464579772,0.986151528027305
799,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.958198000943332,0.986151528027305
800,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,18,Down,0.958439539543556,0.986151528027305
801,WP_MAPK_CASCADE,30,Down,0.958625453822659,0.986151528027305
802,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,7,Down,0.964134546263061,0.988415617793268
803,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.964451781244374,0.988415617793268
804,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.965167655750162,0.988415617793268
805,WP_ESTROGEN_METABOLISM_WP697,5,Down,0.965624480975219,0.988415617793268
806,WP_NUCLEOTIDE_GPCRS,6,Down,0.966961800390054,0.988556480795787
807,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,41,Down,0.970905449744349,0.991358228735246
808,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.973414776811855,0.991807137981548
809,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,61,Up,0.973752396392078,0.991807137981548
810,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.977229299192664,0.992589512935721
811,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.978231271657336,0.992589512935721
812,WP_PEPTIDE_GPCRS,16,Down,0.981725325588069,0.992589512935721
813,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,64,Down,0.982172597608341,0.992589512935721
814,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.982392625662395,0.992589512935721
815,WP_ACUTE_VIRAL_MYOCARDITIS,66,Up,0.982921041310842,0.992589512935721
816,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Down,0.984349121719426,0.992589512935721
817,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.984534430195473,0.992589512935721
818,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,11,Up,0.985361919394926,0.992589512935721
819,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Down,0.987591390313967,0.993620641781085
820,WP_MACROPHAGE_MARKERS,8,Up,0.990313695308982,0.995144493822685
821,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Up,0.992544771785237,0.996171610171785
822,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Up,0.996105289312739,0.997644569246731
823,WP_15Q11Q13_COPY_NUMBER_VARIATION,36,Up,0.996433835546189,0.997644569246731
824,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.998305145441205,0.998305145441205
